An education-behavioural intervention improves adherence to statins

An education-behavioural intervention improves adherence to statins

Bibliographic Details
Main Author:	Kardas Przemyslaw
Format:	Article
Language:	English
Published:	De Gruyter 2013-10-01
Series:	Open Medicine
Subjects:	patient adherence statins hyperlipidemia education-behavioural intervention primary prevention secondary prevention
Online Access:	https://doi.org/10.2478/s11536-013-0170-9

Similar Items

Systematic Review of RCTs Assessing the Effectiveness of mHealth Interventions to Improve Statin Medication Adherence: Using the Behaviour-Change Technique Taxonomy to Identify the Techniques That Improve Adherence
by: Zoe Bond, et al.
Published: (2021-09-01)

Long-term statin adherence in patients after hospital discharge for new onset of atherosclerotic cardiovascular disease: a population-based study of real world prescriptions in Taiwan
by: Shu-ting Chen, et al.
Published: (2019-03-01)

Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry
by: Michael G. Nanna, et al.
Published: (2018-05-01)

Statins in primary prevention: is the enthusiasm justified?
by: Arun K. Chopra, et al.
Published: (2020-07-01)

Prevalence and reasons for non-adherence to hyperlipidemia treatment
by: Kardas Przemyslaw
Published: (2013-10-01)

Contemporary use of lipid-lowering therapy for secondary prevention in Korean patients with atherosclerotic cardiovascular diseases
by: Su-Yeon Choi, et al.
Published: (2020-05-01)

Determinants of Statin Initiation Among Adult Diabetic Patients in Bonga, Ethiopia
by: Kebede zelalem B, et al.
Published: (2020-12-01)

Statins in Secondary Prevention of Atrial Fibrillation
by: V. I. Podzolkov, et al.
Published: (2016-11-01)

Association of Primary Care Providers’ Beliefs of Statins for Primary Prevention and Statin Prescription
by: Jeffrey D. Clough, et al.
Published: (2019-02-01)

Atherosclerosis and Statins
by: Marzieh Shahrezaei, et al.
Published: (2011-07-01)

Improving medication adherence in stroke survivors: the intervention development process
by: Elise Crayton, et al.
Published: (2018-10-01)

A Prognostic Merit of Statins in Patients with Chronic Hemodialysis after Percutaneous Coronary Intervention—A 10-Year Follow-Up Study
by: Takehiro Funamizu, et al.
Published: (2022-01-01)

Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly
by: Sydney B Long, et al.
Published: (2010-12-01)

Pattern of statin use changes following media coverage of its side effects
by: Kriegbaum M, et al.
Published: (2017-07-01)

Cost effectiveness of interventions to improve adherence to statin therapy in ASCVD patients in the United States
by: Armstrong SO, et al.
Published: (2019-08-01)

PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

Correction of Hypercholesterolemia in Primary and Secondary Prevention of Cardiovascular Diseases: Features and Controversial Issues
by: N. M. Akhmedzhanov, et al.
Published: (2019-01-01)

Temporal Trends of High‐Intensity Statin Therapy Among Veterans Treated With Percutaneous Coronary Intervention
by: Aref A. Bin Abdulhak, et al.
Published: (2018-03-01)

Factors Associated with Disparities in Appropriate Statin Therapy in an Outpatient Inner City Population
by: Giselle Alexandra Suero-Abreu, et al.
Published: (2020-09-01)

Utilization of Statins Beyond the Initial Period After Stroke and 1‐Year Risk of Recurrent Stroke
by: Meng Lee, et al.
Published: (2017-08-01)

Statin Eligibility, Coronary Artery Calcium, and Subsequent Cardiovascular Events According to the 2016 United States Preventive Services Task Force (USPSTF) Statin Guidelines: MESA (Multi‐Ethnic Study of Atherosclerosis)
by: Michael D. Miedema, et al.
Published: (2018-06-01)

STATIN GENERICS: EFFICACY AND SAFETY RATIO
by: V. P. Voronina, et al.
Published: (2016-01-01)

Long-Term Benefit and Withdrawal Effect of Statins After Percutaneous Coronary Intervention: A Nationwide Population-Based Cohort Study
by: Jeong HY, et al.
Published: (2020-04-01)

Impact of combination therapy with statin and ezetimibe on secondary prevention for post-acute myocardial infarction patients in the statin era
by: Soichiro Ebisawa, et al.
Published: (2015-09-01)

Statin therapy in multimorbid older patients with polypharmacy- a cross-sectional analysis of the Swiss OPERAM trial population
by: Luise Adam, et al.
Published: (2023-09-01)

It's Not Too Late to Improve Statin Adherence: Association Between Changes in Statin Adherence from Before to After Acute Myocardial Infarction and All‐Cause Mortality
by: Ryan P. Hickson, et al.
Published: (2019-04-01)

New clinical and pharmacological aspects of the use of atorvastatin for primary and secondary prevention of complications of cardiovascular diseases
by: S. R. Gilyarevsky, et al.
Published: (2018-09-01)

Aspirin and statins: possibilities for joint improvement of prognosis in cardiovascular disease
by: К. G. Pereverzeva, et al.
Published: (2019-01-01)

The importance of LDL-C lowering in atherosclerotic cardiovascular disease prevention: Lower for longer is better
by: Omar Mhaimeed, et al.
Published: (2024-06-01)

Statin efficacy in the treatment of hepatitis C genotype I
by: Ahmad Shavakhi, et al.
Published: (2014-01-01)

Impact of adherence, patient perception, and knowledge to statin therapy – A cross-sectional study
by: Siddhi Umarje, et al.
Published: (2021-01-01)

Adherence to Mediterranean diet among patients with acute cardiovascular events admitted in Cardiac Rehabilitation unit
by: Fortuna Lubrano, et al.
Published: (2022-10-01)

Cost-effectiveness analysis of statins in primary care: results from the Arteris cohort study
by: Michel Romanens, et al.
Published: (2021-04-01)

Statins in Healthy Adults: A Meta-Analysis
by: Lee Sandwith, et al.
Published: (2021-06-01)

Association of Contemporary Statin Pretreatment Intensity and LDL-C Levels on the Incidence of STEMI Presentation
by: Ziv Dadon, et al.
Published: (2021-11-01)

Patient‐Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry
by: Corey K. Bradley, et al.
Published: (2019-04-01)

Statins in the primary prevention of cardiovascular disease. Rosuvastatin capabilities
by: Marina G. Bubnova, et al.
Published: (2021-06-01)

High‐Intensity Versus Non‐High‐Intensity Statins in Patients Achieving Low‐Density Lipoprotein Cholesterol Goal After Percutaneous Coronary Intervention
by: Juwon Kim, et al.
Published: (2018-11-01)

Adherence to Statin Therapy Among US Adults Between 2007 and 2014
by: Lisandro D. Colantonio, et al.
Published: (2019-01-01)

Lipid Control Post Coronary Artery Bypass Graft: One Year Follow-Up of a Middle-Eastern Cohort
by: Bassam Atallah, et al.
Published: (2020-02-01)